Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses

Overview of attention for article published in Muscle & Nerve, June 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 3,925)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 42 news outlets
twitter: 5 X users

patent: 6 patents

Readers on

mendeley: 33 Mendeley

So far, Altmetric has seen 12 X posts from 5 X users, with an upper bound of 14,037 followers.

@MichaelWheelson They even said they need to run another trial. https://t.co/R4BaVmo1zM

@Frank_S_David https://t.co/R4BaVmo1zM

@IvanAle98358888 @MilagroError @TheOneAvobeAll @SUgayos Ya, ya. Digo que lo busques. Mira, así https://t.co/n4DfmZPgw8

@farmafilico @Duocem @cogitoe24590723 https://t.co/qvwlcAf28i

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.